Nassif David W. 4
4 · Sio Gene Therapies Inc. · Filed Mar 22, 2021
Insider Transaction Report
Form 4
Nassif David W.
Principal Financial Officer
Transactions
- Award
Common Stock
2021-03-22+15,060→ 34,004 total - Disposition to Issuer
Restricted Stock Units
2021-03-22−15,060→ 0 total→ Common Stock (15,060 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted.